XML 13 R2.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Balance Sheet
Dec. 31, 2020
USD ($)
Current Assets  
Cash $ 1,128,851
Prepaid expenses 34,897
Total Current Assets 1,163,748
Cash and marketable securities held in Trust Account 254,369,267
Total Assets 255,533,015
Current liabilities  
Accrued expenses 364,275
Accrued offering cost 2,500
Total Current Liabilities 366,775
Deferred underwriting fee payable 8,902,250
Warrant liabilities 47,516,962
Total Liabilities 56,785,987
Commitments and Contingencies (see note 7)
Temporary Equity  
Common stock subject to possible redemption, Value 193,747,022
Stockholders' Equity  
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding 0
Additional paid-in capital 39,627,462
Accumulated deficit (34,628,699)
Total Stockholders' Equity 5,000,006
TOTAL LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS' EQUITY 255,533,015
Common Class A [Member]  
Stockholders' Equity  
Common stock 607
Common Class B [Member]  
Stockholders' Equity  
Common stock $ 636 [1]
[1] On November 10, 2020, the Initial Stockholders’ contributed an aggregate of 1,437,500 shares of Class B common stock back to the Company for no consideration, resulting in an aggregate of 7,187,500 shares of Class B common stock issued and outstanding. All share and per-share amounts have been retroactively restated to reflect the stock cancellation (see Note 6).